Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol

Area of Science:

• Biochemistry
• Pharmacology
• Nutrition Science

Background:

• Vitamin E encompasses eight isoforms: four tocopherols (α-, β-, γ-, δ-) and four tocotrienols (α-, β-, γ-, δ-).
• Alpha-tocopherol is the predominant form due to preferential binding by the alpha-tocopherol transfer protein, leading to less research on tocotrienols.
• Tocotrienols exhibit potent antioxidant and anti-inflammatory properties, with unique mechanisms distinct from tocopherols.

Purpose of the Study:

• To review the therapeutic potential and protective effects of various vitamin E isoforms beyond cancer treatment.
• To compare the pharmacological actions of tocopherols and tocotrienols.
• To emphasize the importance of specifying vitamin E isoforms in future research.

Main Methods:

• Literature review and synthesis of existing research on vitamin E isoforms.
• Comparative analysis of antioxidant, anti-inflammatory, and other therapeutic properties.
• Examination of molecular mechanisms of action for tocopherols and tocotrienols.

Main Results:

• Tocotrienols demonstrate superior antioxidant and anti-inflammatory activities compared to alpha-tocopherol.
• Unique properties of tocotrienols include inhibition of HMG-CoA reductase and NF-κB activation, and radioprotection.
• Vitamin E isoforms show protective effects in bone, cardiovascular, eye, kidney, and neurological diseases.

Conclusions:

• Distinguishing between vitamin E isoforms is crucial for accurate research and therapeutic development.
• Tocotrienols possess unique pharmacological benefits that warrant further investigation.
• Specific vitamin E isoforms hold promise as therapeutic agents for various human diseases, including but not limited to cancer.